![1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]- structure](/static/products/2169/21696-13-9.webp)
1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-
TL;DR: 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]- (CAS 21696-13-9) is a chemical compound with molecular formula C26H23BrN6O2 and molecular weight 530.11 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
2-bromo-1-N,4-N-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]benzene-1,4-dicarboxamide
Also Known As: 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-, 2-bromo-1-N,4-N-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]benzene-1,4-dicarboxamide, 2-bromo-N1,N4-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]terephthalamide, 1,4-Benzenedicarboxamide,2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl], 2-Bromo-N~1~,N~4~-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]benzene-1,4-dicarboxamide
| Molecular Formula | C26H23BrN6O2 |
|---|---|
| Molecular Weight | 530.11 g/mol |
| LogP | 2.2 |
| Topological Polar Surface Area | 107.0 Ų |
| Hydrogen Bond Donors | 4 |
| Hydrogen Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Exact Mass | 530.10657 |
| Heavy Atoms | 35 |
| Complexity | 832.0 |
Chemical Identifiers
| CAS Number | 21696-13-9 |
|---|---|
| SMILES | C1CN=C(N1)C2=CC=C(C=C2)NC(=O)C3=CC(=C(C=C3)C(=O)NC4=CC=C(C=C4)C5=NCCN5)Br |
| InChIKey | BHRACASZCXWEOW-UHFFFAOYSA-N |
Product Overview
1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]- (CAS 21696-13-9), with molecular formula C26H23BrN6O2 and molecular weight 530.11 g/mol. IUPAC: 2-bromo-1-N,4-N-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]benzene-1,4-dicarboxamide.
Chemical Property Profile of 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-
Property Insights of 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-
The XLogP value of 2.2 suggests moderate lipophilicity, balancing water solubility and membrane permeability for 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-. The TPSA of 107.0 Ų falls within the moderate polarity range, balancing permeability and solubility for 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-. Following Lipinski's Rule of Five, 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]- has 4 hydrogen bond donor(s) and 4 hydrogen bond acceptor(s), which may warrant consideration for formulation optimization.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-?
The CAS number of 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]- is 21696-13-9.
What is the molecular formula of 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-?
The molecular formula of 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]- is C26H23BrN6O2.
What is the molecular weight of 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-?
The molecular weight of 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]- is 530.11 g/mol.
Where can I buy 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-?
You can request a quote for 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]- directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-?
Yes, KEHONG BIO provides custom synthesis services for 1,4-Benzenedicarboxamide, 2-bromo-N,N'-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]- and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.